{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:02:26Z","timestamp":1789783346555,"version":"4.0.1"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We investigated neurotensin receptor 1 (NTSR1) as a potential mediator of the mechanical immune barrier that contributes to T-cell exclusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary Background Data:<\/jats:title>\n                    <jats:p>The efficacy of immunotherapy in advanced colorectal cancer (CRC) is limited by primary resistance, frequently characterized by an \u201cimmune-excluded\u201d phenotype where physical and biological barriers prevent effector T-cell infiltration. Through its high-affinity receptor, NTSR1, neurotensin signaling has been implicated in tumor progression, yet its role in shaping the immune landscape of CRC remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We integrated transcriptomic and clinical data from The Cancer Genome Atlas discovery cohort with an independent surgical validation cohort from the University of Kentucky. Random Forest machine learning identified molecular features associated with NTS\/NTSR1 signaling, and a 3D tumor spheroid co-culture model was used to evaluate the impact of NTS\/NTSR1 signaling on spatial T-cell distribution\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Dual-cohort analyses revealed high NTSR1 expression as an independent risk factor for progression-free interval in the discovery cohort and overall survival in the validation cohort. Mechanistically, the NTS\/NTSR1 axis upregulates a mechano-structural network centered on PLXNB3, FLNC, and AHNAK2, while simultaneously driving epithelial dedifferentiation through downregulation of core transcription factors (CDX2, SATB2). Together, these transcriptional programs are associated with the remodeling of the tumor microenvironment into an immune-cold, suppressive state. Moreover, 3D modeling indicated that ligand-activated NTS\/NTSR1 signaling restricts T-cell infiltration, which was significantly reversed by the NTSR1 antagonist SR48692, providing functional support for a mechanical immune barrier proposed based on transcriptomic remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Targeting the NTS\/NTSR1 axis may attenuate biological and physical barriers underlying immune exclusion, providing a preclinical rationale for converting immune-excluded CRCs into immune-responsive tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000007131","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:00:10Z","timestamp":1781946010000},"page":"458-471","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Expression of the High-affinity Neurotensin Receptor Defines an Immune\u2011cold, Poor\u2011prognosis Colorectal Cancer Subtype"],"prefix":"10.1097","volume":"284","author":[{"given":"Haoming","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0980-7778","authenticated-orcid":false,"given":"Heidi L.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-9122","authenticated-orcid":false,"given":"Piotr","family":"Rychahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"R1-20260919","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2019.04.003","article-title":"Immunotherapy of colorectal cancer: challenges for therapeutic efficacy","volume":"76","author":"Ciardiello","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R2-20260919","doi-asserted-by":"crossref","first-page":"108962","DOI":"10.1016\/j.clim.2022.108962","article-title":"How to overcome tumor resistance to anti-PD-1\/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC","volume":"237","author":"Chen","year":"2022","journal-title":"Clin Immunol"},{"key":"R3-20260919","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000494410","article-title":"Integrated analysis of the endoscopic, pathological and molecular characteristics of colorectal tumorigenesis","volume":"99","author":"Suzuki","year":"2019","journal-title":"Digestion"},{"key":"R4-20260919","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.3390\/ijms24119644","article-title":"Bradykinin and neurotensin analogues as potential compounds in colon cancer therapy","volume":"24","author":"Szary\u0144ska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R5-20260919","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1021\/acs.analchem.9b03016","article-title":"Separation-based enzymomics assay for the discovery of altered peptide-metabolizing enzymatic activities in biosamples","volume":"91","author":"Ichihashi","year":"2019","journal-title":"Anal Chem"},{"key":"R6-20260919","first-page":"G497","article-title":"Fatty acids stereospecifically stimulate neurotensin release and increase [Ca2+]i in enteric endocrine cells","volume":"261","author":"Barber","year":"1991","journal-title":"Am J Physiol"},{"key":"R7-20260919","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0167-0115(85)90191-0","article-title":"Release and degradation of neurotensin during perfusion of rat small intestine with lipid","volume":"12","author":"Ferris","year":"1985","journal-title":"Regul Pept"},{"issue":"suppl 2","key":"R8-20260919","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0196-9781(81)90043-7","article-title":"Role of nutrients in the gastrointestinal release of immunoreactive neurotensin","volume":"2","author":"Go","year":"1981","journal-title":"Peptides"},{"key":"R9-20260919","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/270183a0","article-title":"Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry","volume":"270","author":"Polak","year":"1977","journal-title":"Nature"},{"key":"R10-20260919","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1748-1716.1979.tb06472.x","article-title":"The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man","volume":"107","author":"Rosell","year":"1979","journal-title":"Acta Physiol Scand"},{"key":"R11-20260919","first-page":"347","article-title":"Neurotensin: a physiological regulator of exocrine pancreatic secretion?","volume":"24","author":"Gullo","year":"1992","journal-title":"Ital J Gastroenteroly"},{"key":"R12-20260919","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature17662","article-title":"An obligatory role for neurotensin in high-fat-diet-induced obesity","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"R13-20260919","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0016-5085(92)91099-P","article-title":"Neurotensin stimulates growth of colonic mucosa in young and aged rats","volume":"103","author":"Evers","year":"1992","journal-title":"Gastroenterology"},{"key":"R14-20260919","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41419-020-03245-8","article-title":"Neurotensin pathway in digestive cancers and clinical applications: an overview","volume":"11","author":"Christou","year":"2020","journal-title":"Cell Death Dis"},{"key":"R15-20260919","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2012.12998","article-title":"Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality","volume":"308","author":"Melander","year":"2012","journal-title":"JAMA"},{"key":"R16-20260919","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s40618-018-0845-9","article-title":"Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus","volume":"41","author":"Barchetta","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"R17-20260919","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.3390\/ijms23042209","article-title":"New insights in the control of fat homeostasis: the role of neurotensin","volume":"23","author":"Barchetta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R18-20260919","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/healthcare11081088","article-title":"Evaluating the feasibility of pro-neurotensin and 25-hydroxyvitamin d3 as possible indicators for type 2 diabetes mellitus and its complications","volume":"11","author":"Mohammed","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"R19-20260919","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/DMSO.S365147","article-title":"Pro-neurotensin as a potential novel diagnostic biomarker for detection of nonalcoholic fatty liver disease","volume":"15","author":"Mohamed","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R20-20260919","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/metabo11060373","article-title":"Circulating levels of pro-neurotensin and its relationship with nonalcoholic steatohepatitis and hepatic lipid metabolism","volume":"11","author":"Villar","year":"2021","journal-title":"Metabolites"},{"key":"R21-20260919","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/jc.2017-02751","article-title":"Increased plasma proneurotensin levels identify NAFLD in adults with and without type 2 diabetes","volume":"103","author":"Barchetta","year":"2018","journal-title":"J Clin Endocrinol Metabol"},{"key":"R22-20260919","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/joim.13651","article-title":"Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD","volume":"294","author":"De Vito","year":"2023","journal-title":"J Intern Med"},{"key":"R23-20260919","doi-asserted-by":"crossref","first-page":"158765","DOI":"10.1016\/j.bbalip.2020.158765","article-title":"Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD","volume":"1865","author":"Dongiovanni","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R24-20260919","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00592-021-01783-x","article-title":"High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up","volume":"59","author":"Cimini","year":"2022","journal-title":"Acta Diabetol"},{"key":"R25-20260919","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2015.05.025","article-title":"Emerging role of neurotensin in regulation of the cardiovascular system","volume":"762","author":"Osadchii","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R26-20260919","doi-asserted-by":"crossref","first-page":"15086","DOI":"10.1038\/s41598-024-65992-4","article-title":"Association between augmented levels of the gut pro-hormone proneurotensin and subclinical vascular damage","volume":"14","author":"De Vito","year":"2024","journal-title":"Sci Rep"},{"key":"R27-20260919","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/ATVBAHA.116.307847","article-title":"Circulating proneurotensin concentrations and cardiovascular disease events in the community","volume":"36","author":"Januzzi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R28-20260919","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1210\/jc.2017-02424","article-title":"Proneurotensin predicts cardiovascular disease in an elderly population","volume":"103","author":"Fawad","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20260919","doi-asserted-by":"crossref","first-page":"117497","DOI":"10.1016\/j.atherosclerosis.2024.117479","article-title":"Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides","volume":"392","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"key":"R30-20260919","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjcard.2018.03.009","article-title":"Usefulness of proneurotensin to predict cardiovascular and all-cause mortality in a United States population (from the Reasons for Geographic and Racial Differences in Stroke Study)","volume":"122","author":"Wettersten","year":"2018","journal-title":"Am J Cardiol"},{"key":"R31-20260919","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1210\/clinem\/dgab755","article-title":"Plasma proneurotensin and prediction of cause-specific mortality in a middle-aged cohort during long-term follow-up","volume":"107","author":"Fawad","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-20260919","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.numecd.2020.11.025","article-title":"Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children","volume":"31","author":"Barchetta","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R33-20260919","doi-asserted-by":"crossref","first-page":"6456257","DOI":"10.1155\/2017\/6456257","article-title":"A review of the role of neurotensin and its receptors in colorectal cancer","volume":"2017","author":"Qiu","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"R34-20260919","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3892\/ijo.2017.3990","article-title":"Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells","volume":"50","author":"Kim","year":"2017","journal-title":"Int J Oncol"},{"key":"R35-20260919","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/1440-1681.12787","article-title":"Oncogenic role of neurotensin and neurotensin receptors in various cancers","volume":"44","author":"Ouyang","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R36-20260919","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00000658-199210000-00005","article-title":"Neurotensin expression and release in human colon cancers","volume":"216","author":"Evers","year":"1992","journal-title":"Ann Surg"},{"key":"R37-20260919","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-7404(92)90025-G","article-title":"Neurotensin stimulates growth of colon cancer","volume":"1","author":"Yoshinaga","year":"1992","journal-title":"Surg Oncol"},{"key":"R38-20260919","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.biochi.2011.04.024","article-title":"The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers","volume":"93","author":"Dupouy","year":"2011","journal-title":"Biochimie"},{"key":"R39-20260919","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jss.2005.04.038","article-title":"Gastrointestinal hormone receptors in primary human colorectal carcinomas","volume":"129","author":"Chao","year":"2005","journal-title":"J Surg Res"},{"key":"R40-20260919","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.peptides.2008.04.014","article-title":"Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma","volume":"29","author":"Gui","year":"2008","journal-title":"Peptides"},{"key":"R41-20260919","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<448::AID-IJC19>3.0.CO;2-N","article-title":"Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice","volume":"80","author":"Maoret","year":"1999","journal-title":"Int J Cancer"},{"key":"R42-20260919","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1787::AID-CNCR22>3.0.CO;2-T","article-title":"Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692","volume":"79","author":"Iwase","year":"1997","journal-title":"Cancer"},{"key":"R43-20260919","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2018.12.007","article-title":"Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody","volume":"444","author":"Wu","year":"2019","journal-title":"Cancer Lett"},{"key":"R44-20260919","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1158\/1078-0432.CCR-06-0968","article-title":"Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells","volume":"12","author":"Wang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R45-20260919","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-10-0659","article-title":"Neurotensin receptor 1 determines the outcome of non-small cell lung cancer","volume":"16","author":"Alifano","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R46-20260919","doi-asserted-by":"crossref","first-page":"e4223","DOI":"10.1371\/journal.pone.0004223","article-title":"The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression","volume":"4","author":"Dupouy","year":"2009","journal-title":"PLoS One"},{"key":"R47-20260919","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/ijc.23710","article-title":"Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway","volume":"123","author":"Shimizu","year":"2008","journal-title":"Int J Cancer"},{"key":"R48-20260919","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/gut.42.4.546","article-title":"Neurotensin receptors: A new marker for human ductal pancreatic adenocarcinoma","volume":"42","author":"Reubi","year":"1998","journal-title":"Gut"},{"key":"R49-20260919","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1158\/0008-5472.CAN-06-0450","article-title":"Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression","volume":"66","author":"Souaz\u00e9","year":"2006","journal-title":"Cancer Res"},{"key":"R50-20260919","doi-asserted-by":"crossref","first-page":"e1440166","DOI":"10.1080\/2162402X.2018.1440166","article-title":"Neurotensin\/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of tumor-associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells","volume":"7","author":"Xiao","year":"2018","journal-title":"Oncoimmunology"},{"key":"R51-20260919","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.142.8.2689","article-title":"Neurotensin regulation of macrophage colony-stimulating factor-stimulated in vitro myelopoiesis","volume":"142","author":"Moore","year":"1989","journal-title":"J Immunol"},{"key":"R52-20260919","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-5793(83)80417-7","article-title":"Neurotensin modulates human neutrophil locomotion and phagocytic capability","volume":"159","author":"Goldman","year":"1983","journal-title":"FEBS Lett"},{"key":"R53-20260919","doi-asserted-by":"crossref","first-page":"941764","DOI":"10.1155\/2013\/941764","article-title":"Neurotensin modulates the migratory and inflammatory response of macrophages under hyperglycemic conditions","volume":"2013","author":"Moura","year":"2013","journal-title":"Biomed Res Int"},{"key":"R54-20260919","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.2147\/OTT.S281517","article-title":"AHNAK2 promotes migration, invasion, and epithelial-mesenchymal transition in lung adenocarcinoma cells via the TGF-\u03b2\/Smad3 pathway","volume":"13","author":"Liu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"R55-20260919","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.18632\/oncotarget.14087","article-title":"Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma","volume":"8","author":"Tanabe","year":"2017","journal-title":"Oncotarget"},{"key":"R56-20260919","doi-asserted-by":"crossref","first-page":"106818","DOI":"10.1016\/j.phrs.2023.106818","article-title":"Targeting the KRT16-vimentin axis for metastasis in lung cancer","volume":"193","author":"Wang","year":"2023","journal-title":"Pharmacol Res"},{"key":"R57-20260919","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10735-025-10550-z","article-title":"Neurotensin receptor1 signaling promotes progression of epithelial\u2013mesenchymal transition in mice with chronic rhinosinusitis through Wnt3a\/\u03b2-catenin pathway","volume":"56","author":"Wu","year":"2025","journal-title":"J Mol Histol"},{"key":"R58-20260919","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41598-020-80336-8","article-title":"Transcript levels of keratin 1\/5\/6\/14\/15\/16\/17 as potential prognostic indicators in melanoma patients","volume":"11","author":"Han","year":"2021","journal-title":"Sci Rep"},{"key":"R59-20260919","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13046-019-1091-5","article-title":"A novel miR-365-3p\/EHF\/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing \u03b25-integrin\/c-met signaling pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R60-20260919","doi-asserted-by":"crossref","first-page":"e32492","DOI":"10.1371\/journal.pone.0032492","article-title":"Kr\u00fcppel-like factor 4 regulates intestinal epithelial cell morphology and polarity","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"R61-20260919","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jpain.2023.02.002","article-title":"PD-1: A new candidate target for analgesic peptide design","volume":"24","author":"Zhao","year":"2023","journal-title":"J Pain"},{"key":"R62-20260919","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40364-025-00835-6","article-title":"Neurotransmitters in tumors: chemical cross-talk shaping tumor progression","volume":"13","author":"Chen","year":"2025","journal-title":"Biomark Res"},{"key":"R63-20260919","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"R64-20260919","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: Removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"R65-20260919","article-title":"Monitoring cancer cell invasion and t-cell cytotoxicity in 3d culture","volume":"160","author":"Lin","year":"2020","journal-title":"J Vis Exp"},{"key":"R66-20260919","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1177\/0962280213515571","article-title":"Summary measure of discrimination in survival models based on cumulative\/dynamic time-dependent ROC curves","volume":"25","author":"Lambert","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"R67-20260919","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-013-1920-3","article-title":"Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells","volume":"389","author":"Zhang","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"R68-20260919","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R69-20260919","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R70-20260919","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroentero Hepatol"},{"key":"R71-20260919","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/biom10081145","article-title":"Characterisation of the expression of neurotensin and its receptors in human colorectal cancer and its clinical implications","volume":"10","author":"Qiu","year":"2020","journal-title":"Biomolecules"},{"key":"R72-20260919","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acs.jproteome.2c00332","article-title":"Glycoproteomics identifies plexin-b3 as a targetable cell surface protein required for the growth and invasion of triple-negative breast cancer cells","volume":"21","author":"Kuhlmann","year":"2022","journal-title":"J Proteome Res"},{"key":"R73-20260919","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/cancers12071816","article-title":"Characterization of class-3 semaphorin receptors, neuropilins and plexins, as therapeutic targets in a pan-cancer study","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R74-20260919","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2010.09.030","article-title":"AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness","volume":"401","author":"Marg","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R75-20260919","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ydbio.2011.10.008","article-title":"Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro","volume":"361","author":"Fujita","year":"2012","journal-title":"Dev Biol"},{"key":"R76-20260919","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J Clin Invest"},{"key":"R77-20260919","doi-asserted-by":"crossref","first-page":"eaaz0868","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"key":"R78-20260919","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-6147(99)01357-7","article-title":"Neurotensin and neurotensin receptors","volume":"20","author":"Vincent","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"R79-20260919","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH775>3.0.CO;2-K","article-title":"Validation of a model of colon cancer progression","volume":"192","author":"Hewitt","year":"2000","journal-title":"J Pathol"},{"key":"R80-20260919","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.91.14.6319","article-title":"Mutator phenotypes in human colorectal carcinoma cell lines","volume":"91","author":"Bhattacharyya","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R81-20260919","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00262-025-03964-x","article-title":"CDX2 and SATB2 loss are associated with myeloid cell infiltration and poor survival in colorectal cancer","volume":"74","author":"Sirni\u00f6","year":"2025","journal-title":"Cancer Immunology Immunother"},{"key":"R82-20260919","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12967-023-04600-x","article-title":"Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"key":"R83-20260919","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"R84-20260919","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"R85-20260919","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/carcin\/bgi269","article-title":"Neurotensin receptor 1 gene activation by the Tcf\/\u03b2-catenin pathway is an early event in human colonic adenomas","volume":"27","author":"Souaz\u00e9","year":"2006","journal-title":"Carcinogenesis"},{"key":"R86-20260919","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fendo.2012.00184","article-title":"Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy","volume":"3","author":"Wu","year":"2013","journal-title":"Front Endocrinol"},{"key":"R87-20260919","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s12276-025-01461-w","article-title":"Neurotensin inhibits AMPK activity and concurrently enhances FABP1 expression in small intestinal epithelial cells associated with obesity and aging","volume":"57","author":"Li","year":"2025","journal-title":"Exp Mol Med"},{"key":"R88-20260919","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41419-025-07664-3","article-title":"Neurotensin promotes hepatic steatosis by regulating lipid uptake and mitochondrial adaptation in hepatocytes","volume":"16","author":"Banerjee","year":"2025","journal-title":"Cell Death Dis"},{"key":"R89-20260919","doi-asserted-by":"crossref","first-page":"110496","DOI":"10.1016\/j.neuropharm.2025.110496","article-title":"Influence of the neurotensin signaling system on feeding and satiety","volume":"275","author":"Thompson","year":"2025","journal-title":"Neuropharmacol"},{"key":"R90-20260919","doi-asserted-by":"crossref","first-page":"e57243","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy","volume":"9","author":"Barrett","year":"2020","journal-title":"eLife"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0000000000007131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:05:43Z","timestamp":1789779943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0000000000007131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000007131","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"2026-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}